SCHEMBL14569795

SCHEMBL14569795

CC(C)C1CCC(C(F)(F)F)(C(F)(F)F)CC1

nearest known ligand 0.30

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.30
OPRD1 P41143 1/20 0.30
OPRK1 P41145 1/20 0.30
OPRL1 P41146 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17467606 0.79
SCHEMBL7919957 0.77 OPRM1 (0.37) OPRM1OPRD1OPRK1OPRL1
SCHEMBL23583202 0.77
SCHEMBL22768733 0.77 OPRM1 (0.37) OPRM1OPRD1OPRK1OPRL1
SCHEMBL19480787 0.76
SCHEMBL681112 0.74
SCHEMBL18236376 0.72
SCHEMBL4762376 0.70
SCHEMBL25162340 0.70
SCHEMBL7897182 0.70 OPRM1 (0.33) OPRM1OPRD1OPRK1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7192957-B2 Compounds as inhibitors of hepatitis C virus NS3 serine protease SCHERING CORPORATION (US) 2007-03-20 US disclosed
US-7192957-B2 Compounds as inhibitors of hepatitis C virus NS3 serine protease SCHERING CORPORATION (US) 2007-03-20 US disclosed